Biopid wins approval for atopic skin disease drug
Biopid announced Tuesday that the Korea Food and Drug Administration approved its product Utoma solution after intensive studies of development.
Utoma induces th...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.